Por favor, use este identificador para citar o enlazar este ítem: https://www.arca.fiocruz.br/handle/icict/32488

Tipo
Artículo
Derechos de autor
Acceso abierto
Fecha del embargo
2020-04-15
Colecciones
Compartir

Estadísticas
Metadatos
Mostrar el registro completo del ítem

ASSOCIATION OF ITRACONAZOLE AND POTASSIUM IODIDE IN THE TREATMENT OF FELINE SPOROTRICHOSIS: A PROSPECTIVE STUDY
Reis, Érica G. et al. | Fecha del documento: 2016
Autor
Reis, Érica G.
Schubach, Tânia M. P.
Pereira, Sandro A.
Silva, Jéssica N.
Carvalho, Beatriz W.
Quintana, Marcel S. B.
Gremião, Isabella D. F.
Afiliación
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatologia Infecciosa. Rio de Janeiro, RJ, Brasil / Federal University of Rio Grande do Sul. Faculty of Veterinary Science. Department of Mycology. Porto Alegre, RS, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Plataforma de Pesquisa Clínica. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Dermatologia Infecciosa. Rio de Janeiro, RJ, Brasil.
Resumen en ingles
Feline sporotrichosis is an endemic disease in Rio de Janeiro, Brazil, where zoonotic transmission of Sporothrix spp. has been reported since 1998. Itraconazole (ITZ) remains the first choice for treating this disease in cats. However, there have been reports of therapeutic failure and a long-term endeavor. Potassium iodide (KI), considered in the past as a drug with variable effectiveness in cats with sporotrichosis, arises as an important option in the treatment of cats from the endemic area of Rio de Janeiro. In order to evaluate the effectiveness of the association of ITZ and KI in naive cats with sporotrichosis, a prospective cohort study was conducted on 30 cats receiving ITZ 100 mg/day and KI 2.5 mg-20 mg/kg/day. Clinical and laboratory adverse effects were assessed once a month according to the standard care protocol. The cure rate was 96.15% within a median of 14 weeks of treatment. Adverse effects were observed in 50% of cats and were managed with a temporary drug suspension and/or a hepatoprotective therapy. The association of ITZ and KI emerges as an effective option for the treatment of feline sporotrichosis.
Palabras clave en ingles
Sporothrix
Cats
Therapy
Potassium iodide
Itraconazole
 
Editor
Oxford University Press
Referencia
REIS, Érica G. et al. Association of itraconazole and potassium iodide in the treatment of feline sporotrichosis: a prospective study. Medical Mycology, v. 54, p. 684-690, 2016.
DOI
10.1093/mmy/myw027
ISSN
1369-3786